Evening salivary alpha-amylase, major depressive disorder, and antidepressant use in the Netherlands Study of Depression and Anxiety (NESDA)

Psychiatry Research

Volumn 208, Issue 1, 2013, Pages 41-46

  Veen, Gerthe ^a,b   Giltay, Erik J ^b   Licht, Carmilla M M ^a   Vreeburg, Sophie A ^a   Cobbaert, Christa M ^b   Penninx, Brenda W J H ^a,b,c   Zitman, Frans G ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Autonomic nervous system; Catecholamines; Heart rate; Heart rate variability; Stress

Indexed keywords

AMYLASE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; DULOXETINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH CARE; NETHERLANDS; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SALIVA ANALYSIS; SALIVA LEVEL; SYMPATHETIC TONE; TREATMENT OUTCOME; UPREGULATION;

ADOLESCENT; ADULT; AGED; ALPHA-AMYLASES; ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; REMISSION INDUCTION; SALIVA;

EID: 84878355977     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.03.012     Document Type: Article

References (50)

1. Bagley S.L., Weaver T.L., Buchanan T.W. Sex differences in physiological and affective responses to stress in remitted depression. Physiology & Behavior 2011, 3(104):180-186.
2. Barton D.A., Dawood T., Lambert E.A., Esler M.D., Haikerwal D., Brenchley C., Socratous F., Kaye D.M., Schlaich M.P., Hickie I., Lambert G.W. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?. Journal of Hypertension 2007, 25:2117-2124.
3. Bosch J.A., de Geus E.J., Veerman E.C., Hoogstraten J., Nieuw Amerongen A.V. Innate secretory immunity in response to laboratory stressors that evoke distinct patterns of cardiac autonomic activity. Psychosomatic Medicine 2003, 65:245-258.
4. Bosch J.A., Veerman E.C., de Geus E.J., Proctor G.B. Alpha-amylase as a reliable and convenient measure of sympathetic activity: don't start salivating just yet!. Psychoneuroendocrinology 2011, 36:449-453.
5. Bruno R.L., Myers S.J., Glassman A.H. A correlational study of cardiovascular autonomic functioning and unipolar depression. Biological Psychiatry 1983, 18:227-235.
6. Carney R.M., Freedland K.E., Veith R.C. Depression, the autonomic nervous system, and coronary heart disease. Psychosomatic Medicine 2005, 67(Suppl 1):S29-S33.
7. Chatterton R.T., Vogelsong K.M., Lu Y.C., Ellman A.B., Hudgens G.A. Salivary alpha-amylase as a measure of endogenous adrenergic activity. Clinical Physiology 1996, 16:433-448.
8. Chatterton R.T., Vogelsong K.M., Lu Y.C., Hudgens G.A. Hormonal responses to psychological stress in men preparing for skydiving. Journal of Clinical Endocrinology & Metabolism 1997, 82:2503-2509.
9. DeCaro J.A. Methodological considerations in the use of salivary alpha-amylase as a stress marker in field research. American Journal of Human Biology 2008, 20:617-619.
10. Esler M.D., Hasking G.J., Willett I.R., Leonard P.W., Jennings G.L. Noradrenaline release and sympathetic nervous system activity. Journal of Hypertension 1985, 3:117-129.
11. Girdler S.S., Hinderliter A.L., Light K.C. Peripheral adrenergic receptor contributions to cardiovascular reactivity: influence of race and gender. Journal of Psychosomatic Research 1993, 37:177-193.
12. Goddard, A.W., Ball, D.G., Matinez, J., Robinson, M.J., Yang, C.R., Russell, J.M., Shekhar, A., 2010. Current perspectives of the roles of the central norepiphrine system in anxiety and depression.
13. Granger D.A., Kivlighan K.T., el Sheikh M., Gordis E.B., Stroud L.R. Salivary alpha-amylase in biobehavioral research: recent developments and applications. Annals of the New York Academy of Sciences 2007, 1098:122-441.
14. Guinjoan S.M., Bernabo J.L., Cardinali D.P. Cardiovascular tests of autonomic function and sympathetic skin responses in patients with major depression. Journal of Neurology, Neurosurgery & Psychiatry 1995, 59:299-302.
15. Hellhammer J., Fries E., Schweisthal O.W., Schlotz W., Stone A.A., Hagemann D. Several daily measurements are necessary to reliably assess the cortisol rise after awakening: state- and trait components. Psychoneuroendocrinology 2007, 32:80-86.
16. Kivlighan K.T., Granger D.A. Salivary alpha-amylase response to competition: relation to gender, previous experience, and attitudes. Psychoneuroendocrinology 2006, 31:703-714.
17. Koller M.M, Purushotham K.R., Maeda N., Scarpace P.J., Humphreys-Beher M.G. Desipramine induced changes in salivary proteins, cultivable oral microbiota and gingival health in aging female NIA Fischer 344 rats. Life Sciences 2000, 15(68):445-455.
18. Koller M.M., Cowman R.A., Humphreys-Beher M.G., Scarpace P.J. An analysis of parotid salivary gland function with desipramine and age in female NIA Fischer 344 rats. Experimental Gerontology 2001, 36:141-157.
19. Kopittke L., Gomez R., Barros H.M. Opposite effects of antidepressants on unstimulated and stimulated salivary flow. Archives of Oral Biology 2005, 50:17-21.
20. Koschke M., Boettger M.K., Schulz S., Berger S., Terhaar J., Voss A., Yeragani V.K., Bar K.J. Autonomy of autonomic dysfunction in major depression. Psychosomatic Medicine 2009, 71:852-860.
21. Krittayaphong R., Light K.C., Golden R.N., Finkel J.B., Sheps D.S. Relationship among depression scores, beta-endorphin, and angina pectoris during exercise in patients with coronary artery disease. Clinical Journal of Pain 1996, 12:126-133.
22. Lederbogen F., Gernoth C., Weber B., Colla M., Kniest A., Heuser I., Deuschle M. Antidepressive treatment with amitriptyline and paroxetine: comparable effects on heart rate variability. Journal of Clinical Psychopharmacology 2001, 21:238-239.
23. Licht C.M., de Geus E.J., van Dyck R., Penninx B.W. Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biological Psychiatry 2010, 68:861-868.
24. Licht C.M., de Geus E.J., Zitman F.G., Hoogendijk W.J., van Dyck R., Penninx B.W Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Archives of General Psychiatry 2008, 65:1358-1367.
25. Light K.C., Bragdon E.E., Grewen K.M., Brownley K.A., Girdler S.S., Maixner W. Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder. Journal of Pain 2009, 10:542-552.
26. Lorentz K. Approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 9. IFCC method for alpha-amylase (1,4-alpha-D-glucan 4-glucanohydrolase, EC 3.2.1.1). International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Committee on Enzymes. Clinical Chemistry and Laboratory Medicine 1998, 36:185-203.
27. Manabe N., Foldes F.F., Torocsik A., Nagashima H., Goldiner P.L., Vizi E.S. Presynaptic interaction between vagal and sympathetic innervation in the heart: modulation of acetylcholine and noradrenaline release. Journal of the Autonomic Nervous System 1991, 32:233-242.
28. Martens E.J., Nyklicek I., Szabo B.M., Kupper N. Depression and anxiety as predictors of heart rate variability after myocardial infarction. Psychological Medicine 2008, 38:375-383.
29. Monteleone P., Scognamiglio P., Monteleone A.M., Mastromo D., Steardo L., Serino I., Maj M. Abnormal diurnal patterns of salivary α-amylase and cortisol secretion in acute patients with anorexia nervosa. World Journal of Biological Psychiatry 2011, 12:455-461. Epub 2011 Jul 11.
30. Nater U.M., La Marca R., Florin L., Moses A., Langhans W., Koller M.M., Ehlert U. Stress-induced changes in human salivary alpha-amylase activity-associations with adrenergic activity. Psychoneuroendocrinology 2006, 31:49-58.
31. Nater U.M., Rohleder N. Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research. Psychoneuroendocrinology 2009, 34:486-496.
32. Nater U.M., Rohleder N., Gaab J., Berger S., Jud A., Kirschbaum C., Ehlert U. Human salivary alpha-amylase reactivity in a psychosocial stress paradigm. International Journal of Psychophysiology 2005, 55:333-342.
33. Nater U.M., Rohleder N., Schlotz W., Ehlert U., Kirschbaum C. Determinants of the diurnal course of salivary alpha-amylase. Psychoneuroendocrinology 2007, 32:392-401.
34. Penninx B.W., Beekman A.T., Smit J.H., Zitman F.G., Nolen W.A., Spinhoven P., Cuijpers P., De Jong P.J., Van Marwijk H.W., Assendelft W.J., van der Meer K., Verhaak P., Wensing M., de Graaf R., Hoogendijk W.J., Ormel J., van Dyck R. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. International Journal of Methods in Psychiatric Research 2008, 17:121-140.
35. Rohleder N., Joksimovic L., Wolf J.M., Kirschbaum C. Hypocortisolism and increased glucocorticoid sensitivity of pro-inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biological Psychiatry 2004, 55:745-751.
36. Rohleder N., Nater U.M., Wolf J.M., Ehlert U., Kirschbaum C. Psychosocial stress-induced activation of salivary alpha-amylase: an indicator of sympathetic activity?. Annals of the New York Academy of Sciences 2004, 1032:258-263.
37. Rohleder N., Nater U.M. Determinants of salivary alpha-amylase in humans and methodological considerations. Psychoneuroendocrinology 2009, 34:469-485.
38. Rohleder N., Wolf J.M., Maldonado E.F., Kirschbaum C. The psychosocial stress-induced increase in salivary alpha-amylase is independent of saliva flow rate. Psychophysiology 2006, 43:645-652.
39. Rush A.J., Gullion C.M., Basco M.R., Jarrett R.B., Trivedi M.H. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychological Medicine 1996, 26:477-486.
40. Skosnik P.D., Chatterton R.T., Swisher T., Park S. Modulation of attentional inhibition by norepinephrine and cortisol after psychological stress. International Journal of Psychophysiology 2000, 36:59-68.
41. Tanaka Y., Ishitobi Y., Maruyama Y., Kawano A., Ando T., Okamoto S., Kanehisa M., Higuma H., Ninomiya T., Tsuru J., Hanada H., Kodama K., Isogawa K., Akiyoshi J. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in major depressive disorder patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012, 30(36):220-224.
42. Thoma M.V., Kirschbaum C., Wolf J.M., Rohleder N. Acute stress responses in salivary alpha-amylase predict increases of plasma norepinephrine. Biological Psychology 2012, 91:342-348.
43. Tulen J.H., Bruijn J.A., de Man K.J., Pepplinkhuizen L., v an den Meiracker A.H., Man in't Veld A.J. Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770). Journal of Clinical Psychopharmacology 1996, 16:135-145.
44. van Veen J.F., van Vliet I.M., DeRijk R.H., van Pelt J., Mertens B., Zitman F.G. Elevated alpha-amylase but not cortisol in generalized social anxiety disorder. Psychoneuroendocrinology 2008, 33:1313-1321.
45. van Zyl L.T., Hasegawa T., Nagata K. Effects of antidepressant treatment on heart rate variability in major depression: a quantitative review. Biopsychosocial Medicine 2008, 2:12.
46. Veen G., Giltay E.J., Vreeburg S.A., Licht C.M.M., Cobbaert C.M., Zitman F.G., Penninx B.W.J.H. Determinants of salivary evening Alpha-Amylase in a large sample free of psychopathology. International Journal of Psychophysiology 2012, 84:33-38.
47. Veith R.C., Best J.D., Halter J.B. Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man. Journal of Clinical Endocrinology & Metabolism 1984, 59:151-155.
48. Veith R.C., Lewis N., Linares O.A., Barnes R.F., Raskind M.A., Villacres E.C., Murburg M.M., Ashleigh E.A., Castillo S., Peskind E.R., et al. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Archives of General Psychiatry 1994, 51:411-422.
49. Yu J.H., Chen Y.Y., Suarez K. Acute amitriptyline effects on parasympathetic-evoked rat saliva. Neuropsychobiology 1989, 20:132-135.
50. Yu J.H. Effects of chronic amitriptyline administration on saliva from the parotid and submandibular glands of the rat. Clinical Autonomic Research 1992, 2:5-15.